{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T23:19:52Z","timestamp":1769210392243,"version":"3.49.0"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"35","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Introduction:<\/jats:title>\n            <jats:p>Chronic myelogenous leukemia (CML), a clonal disorder of pluripotent stem cell, rarely presents with bleeding in chronic phase due to the function preservation of the platelets. Factor (F) XIII deficiency, an extremely rare hemorrhagic disease, can cause fatal bleeding, which has been previously described in autoimmune disorders and leukemias.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 38-year-old woman with a 20-day history of spontaneous subcutaneous hemorrhage visited our hospital, who presented with intracranial hemorrhage, hematuria, and delayed hematoma after a bone marrow puncture. Initial management included cytogenetics analysis, molecular analysis, and coagulation evaluation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>Bone marrow puncture, cytogenetics, and molecular analysis indicated the diagnosis of CML. With the normal results of clotting screening tests and platelet counting, as well as the relief of bleeding after infusion of fresh frozen plasma (FFP), acquired rare bleeding disorder probably associated with factor XIII (FXIII) deficiency.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Management with anti-hyperleukocytosis and chemotherapy, hydration, alkalization, diuresis, uric acid-lowering, molecular targeted drugs, and freshly frozen plasma transfusion therapy resolved the bleeding diathesis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The patient survived from the initial bleeding, however, she died. Twenty six months later due to the progression of CML.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>CML can initially present as unusual bleeding, possibly related to FXIII defect. It is essential to screen coagulopathy including FXIII activity and to supplement plasma for CML patients who present initially as bleeding, which cannot be deciphered by the routine clotting screening test.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000016984","type":"journal-article","created":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T14:30:50Z","timestamp":1567089050000},"page":"e16984","source":"Crossref","is-referenced-by-count":6,"title":["Bleeding with negative coagulation screening test as initial presentation of chronic myelogenous leukemia managed by fresh frozen plasma"],"prefix":"10.1097","volume":"98","author":[{"given":"Yanzhi","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaming","family":"Xi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zijian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230914","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ajh.22031","article-title":"Prediction model for mortality after intracranial hemorrhage in patients with leukemia","volume":"86","author":"Dayyani","year":"2011","journal-title":"Am J Hematol"},{"key":"R2-20230914","first-page":"355","article-title":"[Unusual event during chronic myeloid leukemia; unexpected and apparently spontaneous occurrence of a large intramuscular hematoma of its own clinical peculiarity]","volume":"27","author":"Avogaro","year":"1954","journal-title":"Arch Ital Anat Istol Patol"},{"key":"R3-20230914","first-page":"183","article-title":"[Spontaneous hematoma of the iliac psoas muscle in chronic myeloid leukemia. A case report]","volume":"154","author":"Bauduceau","year":"2003","journal-title":"Ann Med Interne (Paris)"},{"key":"R4-20230914","first-page":"170","article-title":"Chronic myeloid leukemia initially presenting with spontaneous mediastinal hematoma and hemothorax","volume":"63","author":"Kuo","year":"2000","journal-title":"Zhonghua Yi Xue Za Zhi (Taipei)"},{"issue":"(suppl)","key":"R5-20230914","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s00586-008-0863-y","article-title":"Spontaneous spinal epidural hematoma as the initial presentation of leukemia","volume":"18","author":"Nojiri","year":"2009","journal-title":"Eur Spine J"},{"key":"R6-20230914","first-page":"1769","article-title":"[Chronic myeloid leukemia complicated with cerebellar hemorrhage and acute hydrocephalus successfully treated with imatinib and intensive supportive care]","volume":"51","author":"Muta","year":"2010","journal-title":"Rinsho Ketsueki"},{"key":"R7-20230914","first-page":"777","article-title":"Dural metastases in chronic myeloid leukemia presenting as subdural hematoma","volume":"22","author":"Prasad","year":"2012","journal-title":"Turk Neurosurg"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.4103\/0973-1482.146136","article-title":"A rare case of chronic myeloid leukemia with acquired von Willebrand disease presenting as subdural hematoma","volume":"11","author":"Jain","year":"2015","journal-title":"J Cancer Res Ther"},{"key":"R9-20230914","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s11060-010-0278-6","article-title":"Spontaneous acute subdural hematoma as the initial manifestation of chronic myeloid leukemia","volume":"101","author":"Abdulhamid","year":"2011","journal-title":"J Neurooncol"},{"key":"R10-20230914","first-page":"OD03","article-title":"Spontaneous soft tissue haematomas - a rare presentation of chronic myeloid leukemic (CML)","volume":"9","author":"Lakhotia","year":"2015","journal-title":"J Clin Diagn Res"},{"key":"R11-20230914","doi-asserted-by":"crossref","first-page":"864","DOI":"10.4065\/82.7.864","article-title":"How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in adults","volume":"82","author":"Kamal","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"R12-20230914","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3122\/jabfm.2014.04.130227","article-title":"Identification and basic management of bleeding disorders in adults","volume":"27","author":"Kruse-Jarres","year":"2014","journal-title":"J Am Board Fam Med"},{"key":"R13-20230914","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1182\/blood-2014-08-532820","article-title":"Rare bleeding disorders: diagnosis and treatment","volume":"125","author":"Palla","year":"2015","journal-title":"Blood"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.thromres.2012.03.008","article-title":"Acute promyelocytic leukaemia associated Factor XIII deficiency presenting as retro-bulbar haematoma","volume":"129","author":"Goncalves","year":"2012","journal-title":"Thromb Res"},{"key":"R15-20230914","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.3324\/haematol.2013.089045","article-title":"Hyperfibrinolysis and acquired factor XIII deficiency in newly diagnosed pediatric malignancies","volume":"98","author":"Wiegering","year":"2013","journal-title":"Haematologica"},{"key":"R16-20230914","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.thromres.2011.04.014","article-title":"Acquired factor VIII inhibitor as presentation of chronic myelogenous leukemia during interferon-alpha therapy","volume":"128","author":"Zheng","year":"2011","journal-title":"Thromb Res"},{"key":"R17-20230914","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3109\/09537104.2015.1049138","article-title":"Gastrointestinal bleeding in a chronic myeloid leukaemia patient precipitated by dasatinib-induced platelet dysfunction: case report","volume":"26","author":"Kostos","year":"2015","journal-title":"Platelets"},{"key":"R18-20230914","first-page":"684","article-title":"Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes","volume":"6","author":"Rosc","year":"2000","journal-title":"Med Sci Monit"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201908300-00058","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T21:43:43Z","timestamp":1694727823000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201908300-00058"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":18,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000016984","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8]]}}}